Adding checkpoint inhibition immunotherapy to adjuvant #chemotherapy did not improve survival among patients with triple-negative #breastcancer , according to a new study. Heather McArthur, MD, MPH, discusses the results in this #podcast : ow.ly/6k5s50Rfo0F Heather McArthur, MD, MPH
Gratified to see our work on #ctDNA molecular response during #immunotherapy featured in Society for Immunotherapy of Cancer #AACR24 highlights! AACR Johns Hopkins Thoracic Oncology Johns Hopkins Medicine Lavanya Sivapalan sitcancer.org/blogs/thomas-m…
Amazing systematic review and meta-analysis discussing the opportunities and challenges of the disease-modifying immunotherapy for type 1 diabetes: doi.org/10.1016/j.phrs…
#diabetes #immunotherapy #PharmacolRes #openaccess #Research #PharmaTwitter #MedTwitter
Advancing the Fight Against Lung Cancer with TIL Therapy - Nicholas P Restifo
Adam J. Schoenfeld
#Cancer #Immunotherapy #LungCancer #OncoDaily #Oncology
oncodaily.com/45769.html
A standing ovation for NCI Center for Cancer Research's very own Dr. Steven Rosenberg who was awarded the Lifetime Achievement Award at AACR 2024
#AACR24 #Cancer #Cancer Research #Immunotherapy #NCI #OncoDaily #Oncology
oncodaily.com/46006.html
#AILCC24 Keynote Speaker
Thanks Dr. Julie Brahmer for a stellar presentation on immunotherapy: the beginning, the middle, the future. Areas of need:
- IO tox
- IO resistance
- academic studies on relevant questions: e.g. IO duration
IASLC #IrishLungCancerAlliance Johns Hopkins Thoracic Oncology #LCSM
Next BNOS webinar 25th April 4pm 🇬🇧
#Immunotherapy has been transformative for some of our patients with #brainmets but why haven’t we seen the results hoped for with #GBM ?
#nsgy Chiba Ene + #medonc Sophie Berghoff MedUni Wien discuss
eventbrite.co.uk/e/bnos-transla…